Gavreto

(pralsetinib)
NO BOXED WARNING

Dosage & Administration

Select patients for treatment with GAVRETO based on the presence of a RET gene fusion.

The recommended dosage in adults and pediatric patients 12 years and older is 400 mg orally once daily on an empty stomach (no food intake for at least 2 hours before and at least 1 hour after taking GAVRETO).

Get Your Patient on Gavreto

See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:
PrescriberAI
Answers for all your Gavreto label questions.
This AI tool offers medical information for informational purposes only and is not a substitute for professional medical judgment or advice. Physicians and healthcare professionals should exercise their expertise and discretion when interpreting and applying the provided information to specific clinical situations.
What are the indications for Gavreto?
How do you store Gavreto?
What are the dosage forms of Gavreto?
Is Gavreto approved for pregnant women?
What is the generic name of Gavreto?

Gavreto Prescribing Information

Gavreto Prior Authorization Resources

Most recent Gavreto prior authorization forms

Most recent state uniform prior authorization forms

Benefits investigation

Gavreto Financial Assistance Options

Copay savings program

View more

Bridge program

View more

Foundation programs

View more

Gavreto PubMed™ News

5 most recent articles for Gavreto, view all articles on PubMed™
Show the latest PubMed™ articles for Gavreto

Gavreto Patient Education

Patient toolkit

Gavreto FAQs